List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Monoclonal Antibodies Sales Estimates and Forecasts 2017-2028
2.2 Global Monoclonal Antibodies Revenue Estimates and Forecasts 2017-2028
2.3 Global Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Monoclonal Antibodies Sales by Region
2.4.1 Global Monoclonal Antibodies Sales by Region (2017-2022)
2.4.2 Global Sales Monoclonal Antibodies by Region (2023-2028)
2.5 Global Monoclonal Antibodies Revenue by Region
2.5.1 Global Monoclonal Antibodies Revenue by Region (2017-2022)
2.5.2 Global Monoclonal Antibodies Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Monoclonal Antibodies Sales by Manufacturers
3.1.1 Global Top Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.2 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Monoclonal Antibodies in 2021
3.2 Global Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Revenue in 2021
3.3 Global Monoclonal Antibodies Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Monoclonal Antibodies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Monoclonal Antibodies Sales by Type
4.1.1 Global Monoclonal Antibodies Historical Sales by Type (2017-2022)
4.1.2 Global Monoclonal Antibodies Forecasted Sales by Type (2023-2028)
4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
4.2 Global Monoclonal Antibodies Revenue by Type
4.2.1 Global Monoclonal Antibodies Historical Revenue by Type (2017-2022)
4.2.2 Global Monoclonal Antibodies Forecasted Revenue by Type (2023-2028)
4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
4.3 Global Monoclonal Antibodies Price by Type
4.3.1 Global Monoclonal Antibodies Price by Type (2017-2022)
4.3.2 Global Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Monoclonal Antibodies Sales by Application
5.1.1 Global Monoclonal Antibodies Historical Sales by Application (2017-2022)
5.1.2 Global Monoclonal Antibodies Forecasted Sales by Application (2023-2028)
5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
5.2 Global Monoclonal Antibodies Revenue by Application
5.2.1 Global Monoclonal Antibodies Historical Revenue by Application (2017-2022)
5.2.2 Global Monoclonal Antibodies Forecasted Revenue by Application (2023-2028)
5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
5.3 Global Monoclonal Antibodies Price by Application
5.3.1 Global Monoclonal Antibodies Price by Application (2017-2022)
5.3.2 Global Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Monoclonal Antibodies Market Size by Type
6.1.1 North America Monoclonal Antibodies Sales by Type (2017-2028)
6.1.2 North America Monoclonal Antibodies Revenue by Type (2017-2028)
6.2 North America Monoclonal Antibodies Market Size by Application
6.2.1 North America Monoclonal Antibodies Sales by Application (2017-2028)
6.2.2 North America Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 North America Monoclonal Antibodies Market Size by Country
6.3.1 North America Monoclonal Antibodies Sales by Country (2017-2028)
6.3.2 North America Monoclonal Antibodies Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Monoclonal Antibodies Market Size by Type
7.1.1 Europe Monoclonal Antibodies Sales by Type (2017-2028)
7.1.2 Europe Monoclonal Antibodies Revenue by Type (2017-2028)
7.2 Europe Monoclonal Antibodies Market Size by Application
7.2.1 Europe Monoclonal Antibodies Sales by Application (2017-2028)
7.2.2 Europe Monoclonal Antibodies Revenue by Application (2017-2028)
7.3 Europe Monoclonal Antibodies Market Size by Country
7.3.1 Europe Monoclonal Antibodies Sales by Country (2017-2028)
7.3.2 Europe Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Monoclonal Antibodies Market Size by Type
8.1.1 Asia Pacific Monoclonal Antibodies Sales by Type (2017-2028)
8.1.2 Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2028)
8.2 Asia Pacific Monoclonal Antibodies Market Size by Application
8.2.1 Asia Pacific Monoclonal Antibodies Sales by Application (2017-2028)
8.2.2 Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2028)
8.3 Asia Pacific Monoclonal Antibodies Market Size by Region
8.3.1 Asia Pacific Monoclonal Antibodies Sales by Region (2017-2028)
8.3.2 Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Monoclonal Antibodies Market Size by Type
9.1.1 Latin America Monoclonal Antibodies Sales by Type (2017-2028)
9.1.2 Latin America Monoclonal Antibodies Revenue by Type (2017-2028)
9.2 Latin America Monoclonal Antibodies Market Size by Application
9.2.1 Latin America Monoclonal Antibodies Sales by Application (2017-2028)
9.2.2 Latin America Monoclonal Antibodies Revenue by Application (2017-2028)
9.3 Latin America Monoclonal Antibodies Market Size by Country
9.3.1 Latin America Monoclonal Antibodies Sales by Country (2017-2028)
9.3.2 Latin America Monoclonal Antibodies Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Monoclonal Antibodies Market Size by Type
10.1.1 Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2028)
10.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2028)
10.2 Middle East and Africa Monoclonal Antibodies Market Size by Application
10.2.1 Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2028)
10.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2028)
10.3 Middle East and Africa Monoclonal Antibodies Market Size by Country
10.3.1 Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2028)
10.3.2 Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Biocon
11.1.1 Biocon Corporation Information
11.1.2 Biocon Overview
11.1.3 Biocon Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biocon Recent Developments
11.2 Celltrion
11.2.1 Celltrion Corporation Information
11.2.2 Celltrion Overview
11.2.3 Celltrion Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celltrion Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Corporation Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 Hospira
11.4.1 Hospira Corporation Information
11.4.2 Hospira Overview
11.4.3 Hospira Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hospira Recent Developments
11.5 3SBio
11.5.1 3SBio Corporation Information
11.5.2 3SBio Overview
11.5.3 3SBio Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 3SBio Recent Developments
11.6 Accord Healthcare
11.6.1 Accord Healthcare Corporation Information
11.6.2 Accord Healthcare Overview
11.6.3 Accord Healthcare Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Accord Healthcare Recent Developments
11.7 AET Biotech
11.7.1 AET Biotech Corporation Information
11.7.2 AET Biotech Overview
11.7.3 AET Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AET Biotech Recent Developments
11.8 Allergan
11.8.1 Allergan Corporation Information
11.8.2 Allergan Overview
11.8.3 Allergan Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Allergan Recent Developments
11.9 Amega Biotech
11.9.1 Amega Biotech Corporation Information
11.9.2 Amega Biotech Overview
11.9.3 Amega Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amega Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Monoclonal Antibodies Industry Chain Analysis
12.2 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monoclonal Antibodies Production Mode & Process
12.4 Monoclonal Antibodies Sales and Marketing
12.4.1 Monoclonal Antibodies Sales Channels
12.4.2 Monoclonal Antibodies Distributors
12.5 Monoclonal Antibodies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Monoclonal Antibodies Industry Trends
13.2 Monoclonal Antibodies Market Drivers
13.3 Monoclonal Antibodies Market Challenges
13.4 Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Monoclonal Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
